Transforming post-COVID-19 care: Insights into long-haul symptoms and treatment strategies.

The project provided the client with critical insights into long-haul COVID-19 symptoms and management, enabling them to identify key treatment gaps and develop targeted strategies to meet patient needs effectively.

Outcome

  • Mapping analysis of demographics affected by long-haul symptoms, including age, geographical distribution, and common comorbidities to target treatment development.
  • Identification of key healthcare providers and centers specializing in long-haul COVID-19 treatment, establishing crucial partnerships for future clinical trials and therapy introductions.
  • A market entry strategy based on detailed insights into treatment workflows, stakeholder influence, and evolving patient needs to position new therapeutic options effectively.

KEY INTELLIGENCE OBJECTIVES

  • Evaluate the number and demographics of patients experiencing long-haul COVID symptoms to tailor therapeutic strategies effectively.
  • Analyze epidemiological data to estimate the number of long-haul COVID cases, addressing the discrepancy between reported cases and likely unreported or undiagnosed instances.
  • Study the variance in long-haul symptoms experienced by vaccinated versus unvaccinated individuals to understand the impact of vaccination on the severity and spectrum of long-term effects.
  • Analyze variations in the Standard of Care for long-haul COVID-19 treatment across diverse health systems.
  • Document and analyze the progression of long-haul COVID patients from diagnosis to ongoing management, identifying key treatment stages and decision points.
  • Determine the specific healthcare facilities and units where long-haul COVID patients are treated.
  • Review and compare current long-haul COVID-19 treatments to identify leading therapies and innovations.
  • Assess the clinical trial landscape to capture emerging trends and shifts in treatment approaches that could redefine standards of care.
  • Identify and engage with primary stakeholders involved in managing long-haul COVID to understand their influence on treatment and patient outcomes.
  • Pinpoint deficiencies in the current treatment landscape and identify opportunities where innovative solutions could significantly enhance patient outcomes.

Geography

  • Western Europe
  • Central & Eastern Europe
  • Middle East
  • Africa
  • North America
  • South America
  • Other

    • Go back to our case studies

    Welcome to EMBS Group

    Please review the basic information regarding the processing of personal data. The Data Administrator is EMBS GROUP Sp. z o.o. Sp. k. You can contact us via email at gdpr@embs-group.com or our registered office (Poland, 30-224 Kraków, Aleja Sosnowa 2a).

    Please note that any personal data you provide may be used only for the specific purpose for which it was shared. Although providing your data is voluntary, not doing so may limit certain services or actions.

    For more detailed information on processing personal data, including exercising your rights, please refer to our Privacy Policy.

    Accept

    Get the report

    SUBSCRIBE TO MARKET MINDS

    Smart decisions start here.
    Unlock hard-to-get market intelligence to empower your next strategic move.

    Contact us

    Want to talk about your business challenge with us?
    Let us know, we’re always happy to talk.

    EMBS GROUP Sp. z o.o. Sp. k., as the Data Administrator, will process the personal data provided above to respond to the message sent via the form. You can contact us at gdpr@embs-group.com or our registered office (Poland, 30-224 Kraków, Aleja Sosnowa 2a). The full text of the information clause is available in the Privacy Policy.
    Privacy Overview

    EMBS Group, as the Data Administrator, uses cookies to enhance user experience and analyze website traffic. You can change your cookie settings at any time. For more information, please see our Privacy Policy.